Tin tức & Cập nhật

The incidence of atopic diseases in infants born in Hong Kong has increased by 46 percent during the COVID-19 pandemic, potentially linked to altered neonatal microbiome diversity resulting from vigorous disinfection. SIM03 and SIM05, symbiotic formulae developed with the aid of artificial intelligence (AI), are shown to improve eczema severity and quality of life (QoL) in children and adults, respectively, by modulating gut microbiota.

The use of dupilumab in children with moderate-to-severe atopic dermatitis (AD) results in greater improvements in AD severity, better adherence, and fewer treatment-emergent adverse events (TEAEs) than methotrexate (MTX) or cyclosporine, as shown by 2-year interim results from the PEDISTAD study.

The incidence of ocular surface disease associated with dupilumab treatment for moderate-to-severe atopic dermatitis is lower in children and adolescents than that described in adults, suggests a retrospective review at a tertiary paediatric hospital in Singapore

Light sensitivity patterns vary in patients with atopic dermatitis (AD), reports a Scotland study, noting the significance of follow-up assessments because of potential shifts in disease spectrum over time.